Research progress of immunometabolic mechanism for GLP-1 to modulate T cell dysfunction in sepsis
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 4, Pages: 483-489(2025)
Review|更新时间:2025-05-16
分享给微信好友或者朋友圈
导出参考文献
Research progress of immunometabolic mechanism for GLP-1 to modulate T cell dysfunction in sepsis
“The latest research has found that GLP-1 levels increase during sepsis, and GLP-1 R inhibits T lymphocyte glycolysis, providing a new strategy for preventing and treating T lymphocyte dysfunction in sepsis.”
作者机构:
1.解放军总医院第四医学中心急诊医学科,北京 100048
2.解放军总医院医学创新研究部创伤修复与组织再生研究中心,北京 100853
作者简介:
E-mail: z_qinghong@aliyun.com
基金信息:
National Natural Science Foundation of China(82172125)
Liu Hong-Sheng,Zhang Qing-Hong.Research progress of immunometabolic mechanism for GLP-1 to modulate T cell dysfunction in sepsis[J].Medical Journal of Chinese People′s Liberation Army,2025,50(04):483-489.
Liu Hong-Sheng,Zhang Qing-Hong.Research progress of immunometabolic mechanism for GLP-1 to modulate T cell dysfunction in sepsis[J].Medical Journal of Chinese People′s Liberation Army,2025,50(04):483-489. DOI: 10.11855/j.issn.0577-7402.1112.2024.0813.
Research progress of immunometabolic mechanism for GLP-1 to modulate T cell dysfunction in sepsis